This reference uses VA rating codes. For a code from a medical record, check ICD-10-CM and the service date. A clinical code alone does not establish a VA rating or a matching VA diagnostic code.
Immune thrombocytopenia
Hemic and lymphatic · 38 CFR § 4.117
Diagnostic Code 7705 is the VASRD entry for Immune thrombocytopenia. VA applies the controlling criteria, shared formulas, and special instructions shown in 38 CFR Part 4. VMC presents this material for education and reference; it does not determine a Veteran's diagnosis, service connection, or evaluation.
Recorded index labels
These labels are already stored for this diagnostic code. They are not a new condition, rating, or medical relationship.
Appendix C
- Thrombocytopenia
Print the source-verified reference on this page, or choose Save as PDF in your browser’s print dialog.
Source-verified VASRD criteria
How VA rates this diagnostic code
These percentages summarize the regulatory criteria already mapped to this diagnostic code. They do not predict a Veteran's individual evaluation or establish service connection.
Requiring chemotherapy for chronic refractory thrombocytopenia; or a platelet count 30,000 or below despite treatment
Requiring immunosuppressive therapy; or for a platelet count higher than 30,000 but not higher than 50,000, with history of hospitalization because of severe bleeding requiring intravenous immune globulin, high-dose parenteral corticosteroids, and platelet transfusions
Platelet count higher than 30,000 but not higher than 50,000, with either immune thrombocytopenia or mild mucous membrane bleeding which requires oral corticosteroid therapy or intravenous immune globulin
Platelet count higher than 30,000 but not higher than 50,000, not requiring treatment
Platelet count above 50,000 and asymptomatic; or for immune thrombocytopenia in remission
Regulatory notes
- Note (1): Separately evaluate splenectomy under diagnostic code 7706 and combine with an evaluation under this diagnostic code
- Note (2): A 100 percent evaluation shall continue beyond the cessation of chemotherapy. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter
Body system and anatomy metadata
Body system: Hemic and lymphatic
Anatomy / region tags: hematologic
These tags support discovery and body-map compatibility. They do not establish Veteran-specific laterality or entitlement.
Official VA DBQ references
DBQ catalog: va-dbq-2026.09.16 · Retrieved 2026-09-16. Official VA inventory ↗
- Hematologic and Lymphatic Conditions, Including Leukemia ↗ Related resourceCatalog category: Hematologic & Lymphatic
Related by body system only. No reviewed condition-specific form match or requirement has been established.
VA maintains some examination forms that are not available for public use. VMC does not infer a one-code-to-one-DBQ relationship.
Evidence information
When reviewing the criteria, useful evidence categories can include diagnosis and treatment records, objective testing identified by the schedule, documented frequency/duration/severity when the criteria use those concepts, and functional effects described in medical or lay evidence. The relevant evidence depends on the actual claim and medical facts.
VMC does not diagnose conditions, guarantee a percentage, or advise anyone to exaggerate symptoms.
Legal basis and source identification
38 CFR § 4.117 · Source current through 2026-08-06 · Verified 2026-08-10
Registry content release: vasrd-registry-2026.08.1